Matches in SemOpenAlex for { <https://semopenalex.org/work/W2944309091> ?p ?o ?g. }
- W2944309091 abstract "The purpose of this study was to assess the efficacy and safety of biosimilar infliximab (IFX) CT-P13 in treating outpatients with inflammatory bowel disease (IBD) in Italian primary gastroenterology centers.Consecutive IBD outpatients who completed the induction treatment were evaluated retrospectively. Clinical activity was scored according to the Mayo score for ulcerative colitis (UC) and to the Harvey-Bradshaw Index (HBI) for Crohn's disease (CD). The primary endpoint was the achievement of clinical remission (Mayo score ≤2 in UC and HBI ≤5 in CD). Secondary endpoints were clinical response to treatment, achievement of mucosal healing, and safety.One hundred forty-one patients (96 UC and 45 CD) were enrolled. Previous treatment with anti-tumor necrosis factor (TNF)α had been provided to 26% of UC patients and 28.9% of CD patients. Remission was achieved in 57.3% UC patients and in 75.6% CD patients during a median (interquartile range) follow up of 24 (6-24) months. Clinical response and mucosal healing were achieved in 87.5% and 75.0% of UC patients and in 84.4% and 84.2% of CD patients, respectively. By both univariate and multivariate analysis, age >40 years, presence of comorbidities, and naivety to anti-TNFα were significantly related to remission. Only one (0.7%) adverse event was reported in the CD group. Surgery was performed in 2.1% of UC patients and 6.7% of CD patients. Switching from IFX originator to biosimilar did not influence the maintenance of the clinical remission.This study confirmed the long-term efficacy and safety of CT-P13 therapy in IBD, in both naïve patients and those switching from IFX originator." @default.
- W2944309091 created "2019-05-16" @default.
- W2944309091 creator A5012022582 @default.
- W2944309091 creator A5013212525 @default.
- W2944309091 creator A5018440651 @default.
- W2944309091 creator A5028144384 @default.
- W2944309091 creator A5032702653 @default.
- W2944309091 creator A5037310581 @default.
- W2944309091 creator A5045870692 @default.
- W2944309091 creator A5046118125 @default.
- W2944309091 creator A5048084827 @default.
- W2944309091 creator A5048547821 @default.
- W2944309091 creator A5056912422 @default.
- W2944309091 creator A5057265956 @default.
- W2944309091 creator A5057981035 @default.
- W2944309091 creator A5060066646 @default.
- W2944309091 creator A5062205577 @default.
- W2944309091 creator A5071929332 @default.
- W2944309091 creator A5075334973 @default.
- W2944309091 creator A5076254704 @default.
- W2944309091 creator A5077851211 @default.
- W2944309091 creator A5079152597 @default.
- W2944309091 creator A5084275023 @default.
- W2944309091 creator A5085029721 @default.
- W2944309091 date "2019-01-01" @default.
- W2944309091 modified "2023-10-17" @default.
- W2944309091 title "Infliximab biosimilar CT-P13 is effective and safe in treating inflammatory bowel diseases: a real-life multicenter, observational study in Italian primary inflammatory bowel disease centers" @default.
- W2944309091 cites W1827882046 @default.
- W2944309091 cites W1991334020 @default.
- W2944309091 cites W2022888597 @default.
- W2944309091 cites W2024959214 @default.
- W2944309091 cites W2052639260 @default.
- W2944309091 cites W2071662837 @default.
- W2944309091 cites W2102013054 @default.
- W2944309091 cites W2105792933 @default.
- W2944309091 cites W2105872730 @default.
- W2944309091 cites W2120522488 @default.
- W2944309091 cites W2121050884 @default.
- W2944309091 cites W2126807394 @default.
- W2944309091 cites W2127482800 @default.
- W2944309091 cites W2128230250 @default.
- W2944309091 cites W2130173462 @default.
- W2944309091 cites W2154813174 @default.
- W2944309091 cites W2162768160 @default.
- W2944309091 cites W2208243538 @default.
- W2944309091 cites W2231948279 @default.
- W2944309091 cites W2255357183 @default.
- W2944309091 cites W2279977120 @default.
- W2944309091 cites W2308369648 @default.
- W2944309091 cites W2321205867 @default.
- W2944309091 cites W2342216265 @default.
- W2944309091 cites W2521883132 @default.
- W2944309091 cites W2560455300 @default.
- W2944309091 cites W2578994901 @default.
- W2944309091 cites W2613299853 @default.
- W2944309091 cites W2749003136 @default.
- W2944309091 cites W2806699273 @default.
- W2944309091 cites W2887206736 @default.
- W2944309091 cites W2888182383 @default.
- W2944309091 cites W2896737472 @default.
- W2944309091 cites W2897078225 @default.
- W2944309091 cites W2899941886 @default.
- W2944309091 cites W2971987621 @default.
- W2944309091 cites W3015877068 @default.
- W2944309091 doi "https://doi.org/10.20524/aog.2019.0377" @default.
- W2944309091 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6595921" @default.
- W2944309091 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31263362" @default.
- W2944309091 hasPublicationYear "2019" @default.
- W2944309091 type Work @default.
- W2944309091 sameAs 2944309091 @default.
- W2944309091 citedByCount "8" @default.
- W2944309091 countsByYear W29443090912019 @default.
- W2944309091 countsByYear W29443090912020 @default.
- W2944309091 countsByYear W29443090912021 @default.
- W2944309091 countsByYear W29443090912022 @default.
- W2944309091 crossrefType "journal-article" @default.
- W2944309091 hasAuthorship W2944309091A5012022582 @default.
- W2944309091 hasAuthorship W2944309091A5013212525 @default.
- W2944309091 hasAuthorship W2944309091A5018440651 @default.
- W2944309091 hasAuthorship W2944309091A5028144384 @default.
- W2944309091 hasAuthorship W2944309091A5032702653 @default.
- W2944309091 hasAuthorship W2944309091A5037310581 @default.
- W2944309091 hasAuthorship W2944309091A5045870692 @default.
- W2944309091 hasAuthorship W2944309091A5046118125 @default.
- W2944309091 hasAuthorship W2944309091A5048084827 @default.
- W2944309091 hasAuthorship W2944309091A5048547821 @default.
- W2944309091 hasAuthorship W2944309091A5056912422 @default.
- W2944309091 hasAuthorship W2944309091A5057265956 @default.
- W2944309091 hasAuthorship W2944309091A5057981035 @default.
- W2944309091 hasAuthorship W2944309091A5060066646 @default.
- W2944309091 hasAuthorship W2944309091A5062205577 @default.
- W2944309091 hasAuthorship W2944309091A5071929332 @default.
- W2944309091 hasAuthorship W2944309091A5075334973 @default.
- W2944309091 hasAuthorship W2944309091A5076254704 @default.
- W2944309091 hasAuthorship W2944309091A5077851211 @default.
- W2944309091 hasAuthorship W2944309091A5079152597 @default.
- W2944309091 hasAuthorship W2944309091A5084275023 @default.
- W2944309091 hasAuthorship W2944309091A5085029721 @default.
- W2944309091 hasBestOaLocation W29443090911 @default.
- W2944309091 hasConcept C119060515 @default.